ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRON Cronin

3.25
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cronin LSE:CRON London Ordinary Share GB00B29YYY86 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.25 3.10 3.40 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cronin Group PLC Publication of Scientific Paper

19/01/2018 9:00am

RNS Non-Regulatory


TIDMCRON

Cronin Group PLC

19 January 2018

19 January 2018

Cronin Group Plc

("Cronin Group")

Publication of Scientific Paper

Publication in international weekly science journal, Science, of digitization of multi-step organic synthesis

Cronin Group, the AIM listed company focusing on digitizing chemistry, announces that its scientific founder and Non-Executive director, Professor Lee Cronin, has published in Science, the international weekly science journal, a paper demonstrating the digitization of chemistry for synthesis on demand.

The manufacture of active pharmaceutical ingredients ("APIs") is vital for modern healthcare, yet critical drugs are regularly manufactured for a finite period in a limited number of sites. To alleviate this issue, Professor Cronin proposes a concept whereby the large-scale manufacturing process of complex fine chemicals, such as APIs, is augmented by distributed, point-of-use manufacturing in self-contained cartridges requiring limited user interaction to produce the desired products on demand.

Using some 3D printing methodologies covered in Cronin Group's patent US9643152, "Apparatus and methods for the preparation of reaction vessels", the authors demonstrated the translation of benchscale synthesis procedures into a step-by-step workflow that could be used to create digital designs for custom reactionware that can be fabricated by using three-dimensional (3D) printing technologies.

Professor Lee Cronin, Non-Executive director of Cronin Group, commented: "I'm very excited about the different market opportunities which the digitization of chemistry has the potential to open up."

The full manuscript of "Digitization of multi-step organic synthesis in reactionware for on-demand pharmaceuticals" can be found at http://science.sciencemag.org/content/359/6373/314.

For further information:

 
 Cronin Group Plc                 www.croningroupplc.com 
 Mark Warne, Executive Chairman         T: 0141 465 6871 
 
 
   Stockdale Securities Limited         T: 020 7601 6100 
 Tom Griffiths/Edward Thomas 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAKMGMMRLMGRZG

(END) Dow Jones Newswires

January 19, 2018 04:00 ET (09:00 GMT)

1 Year Cronin Chart

1 Year Cronin Chart

1 Month Cronin Chart

1 Month Cronin Chart

Your Recent History

Delayed Upgrade Clock